drugset / Trial / NCT03902912

Effect of Prednisolone Treatment on Uterine Natural Killer Cells

NCT03902912

Phase 3 Recruiting 84 enrolled Chinese University of Hong Kong
NaSingle-groupOpen-labelTreatment

Summary

This study aims to investigate the role of uNK cells and the association with prednisolone.

Timeline

Start
2019-07-30
Primary completion
2027-04-30
Completion
2028-04-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Prednisolone Other / unclassified 10 mg Oral